
GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. (GEHC) Cash on Hand — Cash & Short-Term Investments
Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.
GEHC · cash on hand · updated Dec 31, 2025
Core cash position
as of Dec 31, 2025Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.
Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD
Net cash vs debt
Cash vs Debt · Balance Sheet HealthGE HealthCare Technologies Inc. carries a net debt position of $5.49B. Total debt ($10.00B) exceeds cash on hand ($4.51B). GE HealthCare Technologies Inc. cash vs debt ratio: 31% cash / 69% debt.
Cash on hand history
Annual cash on hand by year
GEHC cash & short-term investments historyHealthcare Sector Cash Reserves Comparison
About cash on hand & methodology
GE HealthCare Technologies Inc. (GEHC) cash on hand as of December 31, 2025 is $4.51B, comprising $4.51B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as GE HealthCare Technologies Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as GE HealthCare Technologies Inc. cash reserves or cash position.
GE HealthCare Technologies Inc. annual cash on hand history shows increased +56.1% in 2025: increased +56.1% in 2025. GE HealthCare Technologies Inc. cash reserves in 2025 reflect the company's capital allocation strategy.
GE HealthCare Technologies Inc. carries total debt of $10.00B against cash of $4.51B, resulting in a net debt position of -$5.49B. For the full balance sheet, see the Financials → Balance Sheet tab.
Frequently asked questions
GEHC cash on hand · 5 questionsAs of December 31, 2025, GE HealthCare Technologies Inc. (GEHC) has $4.51B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $4.51B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $2.29B. Data sourced from the annual 10-K filing via FMP.
▸ Source: FMP /balance-sheet-statement · US GAAP · GE HealthCare Technologies Inc. · GE HealthCare Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025